Pharmaceuticals
- 461
- Arena Pharmaceuticals, Inc.
- Receptor-based drug discovery in the fields of diabetes, obesity, cardiovascular, sleep disorders, neurodegeneration, schizophrenia, depression and anxiety. Profile of company in San Diego, California. (Nasdaq: ARNA)
- 462
- BioSphings AG.
- Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany.
- 463
- Can Fite BioPharma Ltd.
- Developer of anti-arthritis drug CF101 presents its management, technology, and research pipeline. Includes a list of publications and patents.
- 464
- Curis, Inc
- Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)
- 465
- Genfit
- Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research headquartered in Loos, France.
- 466
- Intra-Cellular Therapies, Inc.
- Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters in New York City.
- 467
- Neurocrine Biosciences, Inc.
- Discovers and develops therapeutics for treatment of diseases and disorders of the central nervous and immune systems, including anxiety, depression, alzheimer's disease, obesity, stroke and multiple sclerosis. (Nasdaq: NBIX).
- 468
- Nymox Pharmaceutical Corp.
- Researches and develops neurological diagnostics and pharmaceuticals for the aging population with emphasis on Alzheimer's disease. Profile of company with bases in Maywood, New Jersey and Saint Laurent, Quebec. (Nasdaq: NYMX)
- 469
- Sequenom, Inc.
- Researches and develops high definition dna analysis tools for industrial biomedical and life science applications. (Nasdaq: SQNM).
- 470
- Sierra Sciences Inc.
- Developing drugs and therapies to reverse the effects of human aging by focusing on preserving the length of telomeres, to keep them more resilient. Careers in Reno, Nevada.
- 471
- Trophogen, Inc
- Development of superactive hormones and growth factors for therapeutic applications. Based in Rockville, Maryland, USA.
- 472
- Xencor, Inc.
- Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDA Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
- 473
- Xoma
- Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
- 474
- ARIAD Pharmaceuticals, Inc.
- Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
- 475
- Arqule, Inc.
- Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL)
- 476
- Dendreon Corp.
- Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)
- 477
- Draxis Health Inc.
- Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, Québec. [English, French and Spanish]
- 478
- Exelixis, Inc.
- Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)